Skip to content
value.today

Third Eye Health, Inc.

🇺🇸 Chicago, Illinois, USAHealth CareFounded 2014
Total raised
$28 M
6 rounds on record
Latest round
$6 M
Sep 2023
First round on record
Nov 2016
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Third Eye Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2023$6 MNo. 6$2 to $10 million

Third Eye Health, Inc.: Raise no. 6, Sep 2023

Investors in this round

7 investors had bought by the notice of Sep 11, 2023: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Herbstman · Executive Officer, Director, Promoter
  • Lucas Baran · Executive Officer
  • Kirsten Morbeck · Director
  • Leo Brubaker · Director
  • Mary Kate Salley · Director
  • Rachel Kern · Director
  • Russell Hirsch · Director
  • Steve Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Dan Herbstman, Ceo. Source: SEC Form D, newest notice filed Sep 11, 2023. Read the notice at the SEC.

equitySEC
Jan 2022$4 MNo. 5$2 to $10 million

Third Eye Health, Inc.: Raise no. 5, Jan 2022

Investors in this round

25 investors had bought by the notice of Apr 25, 2022: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Herbstman · Executive Officer, Director
  • Steven Lefar · Executive Officer, Director, Promoter
  • David Reis · Director
  • Kristin Morbeck · Director
  • Mary Kate Salley · Director
  • Russell Hirsch · Director
  • Yaakov Spinrad · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Steven Lefar, Chairman of the Board. Source: SEC Form D, newest notice filed Apr 25, 2022. Read the notice at the SEC.

debt, optionsSEC
Oct 2020$4 MNo. 4$2 to $10 million

Third Eye Health, Inc.: Raise no. 4, Oct 2020

Investors in this round

12 investors had bought by the notice of Dec 3, 2020: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Herbstman · Executive Officer, Director
  • Mary Kate Salley · Executive Officer, Director, Promoter
  • Amish Patel · Director
  • David Reis · Director
  • Russell Hirsch · Director
  • Stefan Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Mary Kate Salley, Ceo. Source: SEC Form D, newest notice filed Dec 3, 2020. Read the notice at the SEC.

debt, optionsSEC
Dec 2019$6 MNo. 3$2 to $10 million

Third Eye Health, Inc.: Raise no. 3, Dec 2019

Investors in this round

30 investors had bought by the notice of Dec 3, 2020: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mary Kate Salley · Executive Officer, Director, Promoter
  • Dan Herbstman · Director
  • David Reis · Director
  • Russell Hirsch · Director
  • Stefan Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”

Signed by Mary Kate Salley, Ceo. Source: SEC Form D, newest notice filed Dec 3, 2020. Read the notice at the SEC.

debt, optionsSEC
Dec 2018$7 MNo. 2$2 to $10 million

Third Eye Health, Inc.: Raise no. 2, Dec 2018

Investors in this round

19 investors had bought by the notice of Jan 23, 2019: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Herbstman · Executive Officer, Director, Promoter
  • Lucas Baran · Executive Officer, Director, Promoter
  • Amish Patel · Director
  • David Reis · Director
  • Katy Fike · Director
  • Russell Hirsch · Director
  • Steven Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which will include normal compensation to executive officers.”

Signed by Daniel Herbstman, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 23, 2019. Read the notice at the SEC.

equity, optionsSEC
Nov 2016$1 MNo. 1Under $2 million

Third Eye Health, Inc.: Raise no. 1, Nov 2016

Investors in this round

1 investor had bought by the notice of Nov 17, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Herbstman · Executive Officer, Director, Promoter
  • Lucas Baran · Executive Officer, Director, Promoter
  • Jamison Feramisco · Director
  • Michael Sachs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital, which will include normal compensation to executive officers.”

Signed by Daniel Herbstman, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 17, 2016. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Third Eye Health, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).

    SEC Form D · Sep 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2023

That is all the official record says: Third Eye Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Third Eye Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 30 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Third Eye Health, Inc.
NameRoleNamed in
Dan HerbstmanExecutive officerSep 2023
Lucas BaranExecutive officerSep 2023
Steven LefarExecutive officerApr 2022
Mary Kate SalleyExecutive officerDec 2020
Daniel HerbstmanExecutive officerJan 2019
Dan HerbstmanDirectorSep 2023
Kirsten MorbeckDirectorSep 2023
Leo BrubakerDirectorSep 2023
Mary Kate SalleyDirectorSep 2023
Rachel KernDirectorSep 2023
Russell HirschDirectorSep 2023
Steve LefarDirectorSep 2023
David ReisDirectorApr 2022
Kristin MorbeckDirectorApr 2022
Steven LefarDirectorApr 2022
Yaakov SpinradDirectorApr 2022
Amish PatelDirectorDec 2020
Stefan LefarDirectorDec 2020
Daniel HerbstmanDirectorJan 2019
Katy FikeDirectorJan 2019
Lucas BaranDirectorJan 2019
Jamison FeramiscoDirectorNov 2016
Michael SachsDirectorNov 2016
Dan HerbstmanPromoterSep 2023
Steven LefarPromoterApr 2022
Mary Kate SalleyPromoterDec 2020
Daniel HerbstmanPromoterJan 2019
Lucas BaranPromoterJan 2019